HonCode

Go Back   HER2 Support Group Forums > Articles of Interest
Register Gallery FAQ Members List Calendar Today's Posts

Reply
 
Thread Tools Display Modes
Old 04-14-2004, 08:52 AM   #1
eric
Guest
 
Posts: n/a
In cancer the goal would be to prevent the formation of blood vessels that a tumor needs to grow. The attack against this process of angiogenesis proposed several years ago by Dr. Judah Folkman of Harvard University has centered on ways to prevent production of cells that will form blood vessels Ye explained.

"In many cases preventing their production is not possible " she said. "Now we might prevent them from doing the right thing as they try to form blood vessels. It is another way of blocking angiogenesis at a different stage."

Egfl7 is produced early in the life of the cells that will form blood vessels she said. It plays its role as they begin to maneuver guiding them into formation of the desired tubular structure.

"Usually most cells in the body are not moving around a lot " she said. "These cells want to move around and align into a tubular formation so they secrete this protein."

Cells usually stop making the protein in most parts of the body after the blood vessels have been built. In adult mice there is some limited production only in organs that require a large blood supply such as the lungs heart and kidneys.


But there is a significant exception to that rule Ye said: "In tumors this gene is turned on again." Lacking that activity a cancer would not have the blood supply it needs for its relentless growth.

Ye and her colleagues already have developed antibodies that interfere with the activity of Egfl7. "We are testing them in tumors to see if we can prevent the tube from being made " she said.

The finding "represents an important step towards understanding of vessel assembly " said Tao P. Zhong an assistant professor of medicine and cell biology at Vanderbilt University Medical Center who has done research on blood vessel formation.

Previous studies have found "very few molecules" involved in the formation of tubular blood vessel structures Zhong said.

"I believe that determining the mechanisms of Egfl7 and its potential signaling pathways may help to unravel potential therapeutic approaches in cancer and cardiovascular disease " he said.

http://www.healthscout.com/news/1/518388/main.html
  Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On

Forum Jump


All times are GMT -7. The time now is 05:28 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter